Craig-Hallum Maintains Buy on Cardlytics, Lowers Price Target to $12

Benzinga · 05/09 15:38
Craig-Hallum analyst Jason Kreyer maintains Cardlytics (NASDAQ:CDLX) with a Buy and lowers the price target from $18 to $12.